Patients Pending, along with its Timesulin connected insulin pen technology, have been acquired by artificial pancreas developer Bigfoot Biomedical for undisclosed terms. As part of the acquisition, John Sjolund, who founded Patients Pending, will join Bigfoot Biomedical.
Bigfoot Biomedical announces acquisition of connected insulin pen tech maker
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.